Skip to content
    XYL
    Earnings call· Jun 2025(Q2 FY25)

    Xylem Q2 FY25 earnings call XYL

    Jul 31, 2025 Source

    Executive summary

    Xylem Q2 FY25 — Record EBITDA Margin and Raised Full-Year Guidance

    Xylem delivered a strong second quarter, marked by record adjusted EBITDA margin and mid-teens adjusted EPS growth, leading to raised full-year guidance for revenue and EPS. The company's simplification efforts and operating model transformation are driving productivity, margin expansion, and improved customer service, despite ongoing macro uncertainties like tariffs and FX. Demand remains resilient across end markets, with strategic acquisitions enhancing the portfolio for future growth.

    Highlights

    5

    • Adjusted EBITDA margin reached a quarterly record of 21.8%, up 100 basis points year-over-year.

    • Adjusted EPS grew mid-teens, with Q2 EPS of $1.26, up 16% versus the prior year.

    • Broad-based organic revenue growth of 6% in the quarter, ahead of expectations.

    • Full-year revenue guidance raised to $8.9 billion to $9 billion, representing 4% to 5% total growth and approximately 4% organic growth.

    • Full-year adjusted EPS guidance raised to $4.70 to $4.85, up from $4.50 to $4.70.

    Concerns

    4

    • Year-to-date free cash flow was down $61 million year-over-year, primarily due to outsourced water projects and timing of tax payments.

    • Water Infrastructure orders declined 2% against difficult comps, driven by funding delays in the U.K. and Canada.

    • China revenue continues to see ongoing economic challenges, with orders down around 18% year-over-year.

    • Tariffs are expected to have a slightly dilutive impact on margin in the back half of the year.

    Guidance & targets

    12
    CategoryTargetConfidence
    Full-year Revenue
    $8.9 billion to $9 billion
    high materiality
    High
    Full-year Total Revenue Growth
    4% to 5%
    high materiality
    High
    Full-year Organic Revenue Growth
    approximately 4%
    high materiality
    High
    Full-year Adjusted EBITDA Margin
    21.3% to 21.8%
    high materiality
    High
    Full-year Adjusted EBITDA Margin Expansion
    70 to 120 basis points
    high materiality
    High
    Full-year Adjusted EPS
    $4.70 to $4.85
    high materiality
    High
    Full-year Free Cash Flow Margin
    9% to 10%
    medium materiality
    High
    Q3 Revenue
    $2.2 billion
    medium materiality
    High
    Q3 Organic Revenue Growth
    4% to 5%
    medium materiality
    High
    Q3 Adjusted EBITDA Margin
    21.7% to 22.2%
    medium materiality
    High
    Q3 Adjusted EPS
    $1.20 to $1.25
    medium materiality
    High
    Measurement & Control Solutions Book-to-Bill Ratio
    positive
    medium materiality
    High

    Segment performance

    4
    SegmentRevenueYoYQoQMargin
    Measurement & Control Solutions (MCS)
    Driven by energy metering demand and backlog execution. Margin down 30 bps YoY due to inflation and mix, offset by productivity, volume, price. Acceleration in higher-margin energy orders helped offset negative impact of unfavorable legacy projects.
    Orders grew 12% organicallyBacklog remains healthy at $1.7 billion
    		up 10%10%—23.1%
    Water Infrastructure (WI)
    Demand strong across most regions/end markets. Growth led by treatment demand and all regions except China. Margin expanded 200 bps driven by productivity and price, partially offset by inflation.
    Book-to-bill was above 1Orders declining by 2%
    		grew 4%4%—21.8%
    Applied Water (AW)
    Strength in commercial buildings and U.S. Margin expanded 420 bps driven by productivity and price, partially offset by inflation including tariffs. Segment setting pace for 80/20 benefits.
    Orders rose for the sixth straight quarter, up 4%
    		increased 5%5%—21.7%
    Water Solutions & Services (WSS)
    Contributions from capital projects and services. Margin expanded 60 bps reflecting strong execution on price and productivity, divestitures and revenue synergies, partially offset by inflation.
    Orders increased 5%, led by services for utility and power end markets
    		grew 5%5%—24.4%

    Operational metrics

    6
    Net debt to adjusted EBITDA
    0.4x
    Q2 FY25

    reflecting our strong balance sheet and capacity for continued investment.

    On-time performance
    up 600 basis pointsyear-over-year
    June

    Year-to-date, we're close to 300 [bps].

    EBITDA margin impact from tariffs
    10 to 25 basis pointspressure on year-over-year EBITDA margin expansion
    back half of the year

    a little bit of dilutive nature of the tariffs

    Corporate expenses
    increased by $10 million to $15 million
    FY25

    a combination of FX and variable comp relative to the stronger results.

    Applied Water EBITDA margin expansion drivers
    2/3
    Q2 FY25

    No, I don't think any one-timers for me, there's an element of about 2/3 of that -- of that is the significant traction they made on 80/20 and then positive price/cost.

    Data center water usage
    5 million gallonsequivalent to a population of 50,000 people
    per day

    Data centers take about 50 -- what is it? It represents about 50,000 people in terms of a population and it's about 5 million gallons of water a day that they're using.

    Industry KPIs

    4
    MetricValueDetails
    Tariff cost impact10 to 25 basis pointsbps
    Data center prime power demand5 million gallonsgallons
    Incremental margin operating leverage420 basis pointsbps
    Order backlog order intake by segmentOrders up 4%%

    Orderbook & backlog

    2
    Total Backlogabove $5 billionQ2 FY25
    Measurement & Control Solutions Backlog$1.7 billionQ2 FY25

    being worked down to a more normalized level

    Deals & partnerships

    2
    VacomProprietary solutions in zero liquid discharge.

    Vacom brings proprietary breakthrough solutions in 0 liquid discharge which offers compelling value propositions to attractive industrial verticals like microelectronics and energy.

    EnvirexLeader in nonmechanical mixing and biological process solutions.

    Envirex represents another enhancement to our advanced treatment portfolio. The company is a leader in nonmechanical mixing and biological process solutions, which enhances our ability to serve one of the fastest-growing segments in water, advanced nutrient removal.

    Risks & headwinds

    7
    Tariff Uncertaintyback half of the year

    slightly dilutive impact on margin (10-25 bps pressure on YoY EBITDA margin expansion in H2).

    Mitigation: Targeted pricing actions and accelerated supply chain adjustments.

    Inflation

    Offset by pricing and supply chain actions.

    Mitigation: Pricing and supply chain actions, productivity.

    China Economic ChallengesOngoing

    Water Infrastructure revenue impacted, orders down around 18% year-over-year (for Xylem overall in China).

    Mitigation: Intentional strategy to walk away from less effective parts of the business outside developed markets.

    Funding Delays in UK and CanadaExpected to resolve in second half of the year.

    Water Infrastructure orders declined 2% against difficult comps.

    Mitigation: Expectation for delays to snap back in H2.

    Macro Uncertainty

    Could impact performance.

    Mitigation: Controlling what can be controlled, strong demand, backlog execution, simplification benefits.

    Lower-margin legacy projects (MCS)Q3 FY25

    50 to 100 basis points pressure on sequential margins in Q3 for MCS.

    Mitigation: Efforts to negotiate additional pricing.

    Potential US Municipal Funding DeclineFuture administration

    SRF funding makes up 5% of muni budgets ($3 billion historically).

    Mitigation: Expectation that Congress will appropriate money to maintain healthy SRF levels.

    What to watch in Q3 FY25

    5

    MCS Book-to-Bill Ratio

    as we close the year
    Currentnear 1 (year-to-date company-wide), below 1 (MCS, as they are working down backlog)
    Targetpositive

    Why it matters

    Indicates whether MCS is growing its backlog or eating into it, crucial for future revenue.

    Yes, we have single signaled that MCS will be back to book-to-bill positive as we close the year and we maintain that expectation.

    Q&A highlights

    6

    Update on MCS orders, destocking, customer sentiment, and timeline for book-to-bill to reach 1.

    Commercial demand remains strong. Sequential improvement in orders expected in H2. MCS is working down backlog to normalized levels. Expect book-to-bill to be positive by year-end.

    “Yes, we have single signaled that MCS will be back to book-to-bill positive as we close the year and we maintain that expectation.”

    asked by Michael Halloran · answered by William Grogan

    2 min read7 chapters

    Detailed Narrative

    01

    Operating Model Transformation and Simplification Benefits

    Xylem's operating model transformation, launched last September, is yielding significant results. The company achieved a new record for on-time performance in Q2, up 600 basis points year-over-year in June, demonstrating increased speed and agility. Simplification efforts, including 80/20 principles, have reduced complexity, enabled faster decision-making, and are driving margin expansion and improved customer responsiveness across segments, particularly in Applied Water and Water Infrastructure.

    02

    Evoqua Integration and Revenue Synergies

    Two years post-close, the integration with Evoqua has been highly successful, delivering cost synergies ahead of schedule. The combined portfolio is showing strong traction on revenue synergies in both industrial and utility end markets. Deep cultural integration has been a key focus, fostering alignment and quick strategy execution, which is visible in the teams' performance.

    03

    Strategic Acquisitions in Advanced Treatment

    Xylem made two targeted acquisitions: Vacom and Envirex. Vacom offers proprietary zero liquid discharge solutions for industrial verticals like microelectronics and energy. Envirex enhances the advanced treatment portfolio with nonmechanical mixing and biological process solutions, improving the ability to serve the advanced nutrient removal segment. These acquisitions reflect a strategy to invest in high-value capabilities that drive profitable growth.

    04

    Resilient Demand and Backlog Health

    Despite global volatility🌐 and macro uncertainty🌐, demand for Xylem's products and solutions remains resilient. Orders were up 4% overall, with year-to-date book-to-bill near 1. The total backlog remains strong at over $5 billion, with MCS backlog being worked down to a more normalized level but still healthy at $1.7 billion. The company is not seeing material demand pull-forward📎 from the second half.

    05

    Tariff Impacts and Mitigation Strategies

    Xylem has proactively mitigated tariff impact🌐s through targeted pricing actions and accelerated supply chain adjustments. While current and announced tariff structures (including Section 232 tariffs on steel and aluminum) are assumed to remain, the company is confident that these actions will substantially offset costs, though a slightly dilutive impact on margin is expected in the back half of the year.

    06

    US Municipal Funding Outlook

    Concerns regarding potential declines in US municipal utility funding under a different administration were addressed. Management noted that 75% of demand is OpEx and infrastructure is aging. While SRF funding is a watch item, it historically makes up only 5% of muni budgets, and Congress is expected to appropriate funds to maintain healthy SRF levels, mitigating significant negative impact.

    07

    Data Center Water Demand

    Data centers are emerging as a significant water consumer, using approximately 5 million gallons per day, equivalent to a population of 50,000. While not a meaningful driver in the next year, this trend is expected to become a multi-year driver (3-5 years) as municipalities face stress, increasing the need for water reuse and filtration solutions, particularly in Water Solutions and Services.

    AI-generated summary of the company’s earnings call. Not investment advice.